Trial Profile
Nitisinone in patients with restless legs syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2011
Price :
$35
*
At a glance
- Drugs Nitisinone (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 25 Jul 2011 New trial record
- 09 Jun 2011 Results presented at the 15th International Congress of Parkinson's Disease and Movement Disorders.